epoc NXS Host 11413475
by Epocal Inc
epoc NXS Host 11413475 (16266) is a metabolic profile clinical chemistry analyser IVD (FDA Class I) made by Epocal Inc, cleared under FDA 510(k) K200107 on 5 Jun 2020 and listed in FDA GUDID since 18 Jun 2020 (UDI-DI 00630414606095), active as of 23 Oct 2026. 19 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
18 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00630414606095 | Date18 Jun 2020 | StatusListed |
| United States | FDA 510(k)SESE | NumberK200107 | Date5 Jun 2020 | StatusActive |
Official records
- AccessGUDID record 00630414606095
- FDA 510(k) database K200107
From the FDA record
- Device description
- The epoc Blood Analysis System, is intended for use by trained medical professionals as an in vitro diagnostic device for thequantitative testing of samples of heparinized or un-anticoagulated arterial, venous or capillary whole blood in the laboratoryor at the point of care in hospitals, nursing homes or other clinical care institutions.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K200107 decided 5 Jun 2020 Active
- FDA GUDID UDI-DI 00630414606095 listed 18 Jun 2020 Listed
Recalls
-
- Ongoing Z-2005-2026
Use of the affected product can result in discrepant low pH and measured Total Carbon Dioxide (mTCO2) results and corresponding calculated values in arterial, venous, and capillary patient samples. An erroneously low pH or mTCO2 reading can lead to inappropriate treatment of nonexistent acidosis (respiratory of metabolic) or missed diagnosis of alkalosis (a true high pH: respiratory or metabolic alkalosis), potentially causing harm through unnecessary interventions with the former or failure to deliver appropriate treatment with the latter.
-
- Ongoing Z-2272-2025
Siemens Healthcare Diagnostics Inc. has confirmed that a negative sodium bias may exist in some epoc test card lots. All other analytes are performing as intended. The observed average bias for sodium was -4.4 mmol/L. The maximum bias observed was -14 mmol/L, which occurred at a higher sodium concentration around 150 mmol/L. No positive bias has been observed. Quality Control (QC) fluid may or may not detect the issue depending on the bias magnitude and the frequency of QC testing.
-
- Ongoing Z-1685-2025
- Ongoing Z-1684-2025
The occurrence of discrepant high pH results in samples introduced with higher injection volumes with epoc sensor configuration 45.n.
-
- Ongoing Z-0741-2025
- Ongoing Z-0735-2025
- Ongoing Z-0739-2025
- Ongoing Z-0740-2025
- Ongoing Z-0734-2025
- Ongoing Z-0736-2025
- Ongoing Z-0738-2025
- Ongoing Z-0737-2025
Siemens Healthcare Diagnostics is recalling their epoc Blood Analysis System because of a software malfunction that occurs when specific criteria are met that can result in the incorrect patient name being assigned to a blood measurement by the device if the user of the device does not ensure verification of the correct patient name. The software malfunction has the potential to impact patient safety via misdiagnosis and/or mistreatment by a clinician if the wrong patient information is saved with the test result from the subject device.
-
- Ongoing Z-0286-2025
Siemens Healthcare Diagnostics Inc. has confirmed that a negative sodium bias may exist in one lot of epoc BGEM BUN Test Cards approximately 2 months prior to expiration. The observed maximum negative bias from internal testing is -10 mmol/L. No positive bias has been observed. Quality Control (QC) fluid may or may not detect the issue depending on the bias magnitude and the frequency of QC testing. One customer complaint has been associated with this issue. No adverse events have been reported. All affected lots have recently expired before the issuance of the recall.
-
- Ongoing Z-0601-2024
Siemens Healthcare Diagnostics Inc. has confirmed a potential issue that could occur under certain conditions, a software problem is causing erroneous results to be printed. When the results are run on the epoc NXS Host and Delete Blood Tests feature is enabled, the results that are generated at the time of testing are correct; however, when this issue occurs, results that are printed, saved and/or transferred to a data manager, may include unselected analytes that are from a previous patient or QC test. The worst possible outcome may result in a failure to diagnose hyperkalemia, due to an erroneous depressed potassium level or inappropriate treatment to hyperglycemia due to erroneous glucose reading.
-
- Ongoing Z-2477-2023
- Ongoing Z-2476-2023
- Ongoing Z-2478-2023
There is potential for discrepant high glucose results in samples with glucose results on the lower end of the reportable range.
-
- Ongoing Z-1215-2023
pO2 High Recovery in Quality Control When Adjusted for Barometric Pressure
-
- Terminated Z-2970-2020
Sporadically inconsistent discrepant (low bias) glucose results on card lot 01-20095-10. Potential exists for a delay in diagnosis of hyperglycemia or unnecessary treatment for hypoglycemia.
Timeline
- Recall initiated FDA recalls Z-0739-2025
- Recall initiated FDA recalls Z-0740-2025
- Recall initiated FDA recalls Z-0734-2025
- Recall initiated FDA recalls Z-0736-2025
- Recall initiated FDA recalls Z-0738-2025
- Recall initiated FDA recalls Z-0737-2025
- Recall initiated FDA recalls Z-1685-2025
- Recall initiated FDA recalls Z-1684-2025
- Recall initiated FDA recalls Z-2272-2025
- Recall initiated FDA recalls Z-2005-2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- epoc NXS Host
- Generic name
- Metabolic profile clinical chemistry analyser IVD
- Model / Ref / Catalog
- 11413475, 16266
- Primary DI / UDI-DI
- 00630414606095
- 510(k) Number
- FDA product code
- KHP, CEM, CGZ, JGS, JFP, CHL, JFL, CGA
- GMDN term
- Metabolic profile clinical chemistry analyser IVD
- Device class
- Class I
- Regulation number
- 862.1450, 862.1600, 862.1170, 862.1665, 862.1145, 862.1120, 862.1160, 862.1345
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Metabolic profile clinical chemistry analyser IVD.